"Join FLCCC Senior Fellows Dr. Ryan Cole and Dr. Jessica Rose as they explore the startling findings from recent studies on vaccine-related deaths. Dr. Rose's research shows a dramatic increase in autopsies linked to adverse events following COVID-19 vaccinations compared to influenza vaccines, with a significant number of cases involving cardiovascular issues such as myocarditis, cardiac arrest, and pulmonary embolism."
Rose: "If you were at all looking at the data, pharmacovigilance data or case report data or data published in the peer-reviewed literature, you’re starting to notice the snowball getting bigger with regard to the safety profile of the COVID-19 injectable products...
There was actually a 1,714% increase in absolute count of autopsies in VAERS when comparing the influenza vaccine to the COVID-19 injectable product reports. But there was a 77.6% decrease in the rate of autopsy reporting in the context of deaths...
People shouldn’t be dying in large numbers or excessive numbers that would never have been accepted before the COVID era, at the hands of therapeutic that’s supposed to save them from death...
The lipid nanoparticles carrying the mRNA can travel throughout the body, potentially reaching the brain, heart, and other vital organs. This unpredictability means we don’t know where these nanoparticles will settle or how much spike protein they will produce. There’s literally no off switch...
Cole: ”The body’s immune response to these foreign proteins could trigger autoimmune reactions, leading to long-term health complications."
Terms and Conditions
https://covid19criticalcare.com/about-the-flccc/terms-and-conditions/
FLCCC publishes content under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which requires:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.